Navegar por autor "Calvo Crespo, Patricia"

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1

2014- Fachal Vilar, Laura; Vega Gliemmo, Ana; Carracedo Álvarez, Ángel; Sanchez Garcia, Manuel; Lobato Busto, Ramón; [et al.]

Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients

2012- Fachal Vilar, Laura; Vega Gliemmo, Ana; Carracedo Álvarez, Ángel; Sanchez Garcia, Manuel; Lobato Busto, Ramón; [et al.]

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study

2020- Zapatero, A.; Gómez Caamaño, Antonio; Cabeza Rodriguez, M.; Muinelo Romay , Laura; Martin de Vidales, C.; [et al.]

Dolor irruptivo oncologico inducido por radioterapia: ?es posible optimizar su tratamiento?

2015- Gómez Fernández, Rocio del Carmen; Castro Gómez, José Enrique; Calvo Crespo, Patricia; Victoria Fernández, Concepción

Evaluating the role of mitochondrial DNA variation to the genetic predisposition to radiation-induced toxicity

2014- Fachal Vilar, Laura; Vega Gliemmo, Ana; Sanchez Garcia, Manuel; Lobato Busto, Ramón; Gómez Caamaño, Antonio; [et al.]

High-dose neoadjuvant radiochemotherapy followed by surgery in MRI and EUS-defined poor-risk rectal cancer

2011- Iglesias García, Julio; Luna Vega, Victor; Gómez Caamaño, Antonio; Peleteiro Higuero, Paula; Carballo Castro, Ana María; [et al.]

Hiperfracctioned Radiochemotherapy in Small Cell Lung Cancer, a Monoinstutional Experience

2015- Lazaro Quintela, Martín; Gómez Caamaño, Antonio; Calvo Crespo, Patricia; Taboada Valladares, Maria Begoña

Induction chemotherapy with docetaxel (D) and cisplatin (C) followed by concurrent thoracic radiotherapy with biweekly d and C for stage III non-small cell lung cancer (NSCLC) - A galician lung cancer group study

2011- Anido Herranz, Urbano; Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Calvo Crespo, Patricia; Vázquez Estévez, Sergio; [et al.]

Neoadyuvant radiochemotherapy for metastatic rectal cancer

2012- Luna Vega, Victor; Castro Gómez, José Enrique; Gómez Caamaño, Antonio; Peleteiro Higuero, Paula; Carballo Castro, Ana María; [et al.]

No association between typical European mitochondrial variation and prostate cancer risk in a Spanish cohort

2014- Fachal Vilar, Laura; Gómez Caamaño, Antonio; Alvarez Iglesias, V.; Gómez Carballa, A.; Calvo Crespo, Patricia; [et al.]

Phase III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for SMALL-CELL LUNG Cancer

2019- De Dios, N. R.; Murcia, M.; Counago, F.; Lopez, J.; Oses, M. R.; [et al.]

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

2019- Seibold, P.; Webb, A.; Aguado-Barrera, M. E.; Azria, D.; Bourgier, C.; [et al.]

Single fraction (7 Gy) of HDR-brachytherapy as boost in breast-conserving therapy: 5 years results in 139 patients

2012- González Patiño, Ezequiel; Luna Vega, Victor; Castro Gómez, José Enrique; Calvo Crespo, Patricia; Taboada Valladares, Maria Begoña; [et al.]

SNPS in DNA repair and damage detection genes and acute normal tissue toxicity in prostate cancer patients

2012- Fachal Vilar, Laura; Vega Gliemmo, Ana; Carracedo Álvarez, Ángel; Sanchez Garcia, Manuel; Lobato Busto, Ramón; [et al.]

Repositorio digital RUNA

Navegar por autor "Calvo Crespo, Patricia"

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1 ﻿

Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients ﻿

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study ﻿

Dolor irruptivo oncologico inducido por radioterapia: ?es posible optimizar su tratamiento? ﻿

Evaluating the role of mitochondrial DNA variation to the genetic predisposition to radiation-induced toxicity ﻿

High-dose neoadjuvant radiochemotherapy followed by surgery in MRI and EUS-defined poor-risk rectal cancer ﻿

Hiperfracctioned Radiochemotherapy in Small Cell Lung Cancer, a Monoinstutional Experience ﻿

Induction chemotherapy with docetaxel (D) and cisplatin (C) followed by concurrent thoracic radiotherapy with biweekly d and C for stage III non-small cell lung cancer (NSCLC) - A galician lung cancer group study ﻿

Neoadyuvant radiochemotherapy for metastatic rectal cancer ﻿

No association between typical European mitochondrial variation and prostate cancer risk in a Spanish cohort ﻿

Phase III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for SMALL-CELL LUNG Cancer ﻿

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer ﻿

Single fraction (7 Gy) of HDR-brachytherapy as boost in breast-conserving therapy: 5 years results in 139 patients ﻿

SNPS in DNA repair and damage detection genes and acute normal tissue toxicity in prostate cancer patients ﻿

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1

Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study

Dolor irruptivo oncologico inducido por radioterapia: ?es posible optimizar su tratamiento?

Evaluating the role of mitochondrial DNA variation to the genetic predisposition to radiation-induced toxicity

High-dose neoadjuvant radiochemotherapy followed by surgery in MRI and EUS-defined poor-risk rectal cancer

Hiperfracctioned Radiochemotherapy in Small Cell Lung Cancer, a Monoinstutional Experience

Induction chemotherapy with docetaxel (D) and cisplatin (C) followed by concurrent thoracic radiotherapy with biweekly d and C for stage III non-small cell lung cancer (NSCLC) - A galician lung cancer group study

Neoadyuvant radiochemotherapy for metastatic rectal cancer

No association between typical European mitochondrial variation and prostate cancer risk in a Spanish cohort

Phase III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for SMALL-CELL LUNG Cancer

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Single fraction (7 Gy) of HDR-brachytherapy as boost in breast-conserving therapy: 5 years results in 139 patients

SNPS in DNA repair and damage detection genes and acute normal tissue toxicity in prostate cancer patients